Drug Type Synthetic peptide |
Synonyms- |
Target |
Action- |
Mechanism PLA2R inhibitors(phospholipase A2 receptor 1 inhibitors), sPLA2 inhibitors(Secretory phospholipase A2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Autoimmune Diseases | Discovery | - | 02 Jul 2024 | |
| Neoplasms | Discovery | - | 02 Jul 2024 | |
| Other Diseases | Discovery | - | 02 Jul 2024 |





